Réunions scientifiques mensuelles

Au cours de chaque année académique, le département d’ophtalmologie organise, une série de 9 réunions scientifiques. L’objectif est de partager avec toute la communauté de l’ophtalmologie, des présentations de haut calibre, données par des spécialistes tant locaux qu’internationaux, invités à tour de rôle par les chefs de divisions.

Comité organisateur: Dr Patrick Hamel, professeur agrégé de clinique et chef du département d’ophtalmologie du CHU Saint-Justine & Dre Isabelle Hardy, directrice du département de l’Université de Montréal.

Le département remercie l’Association des Médecins Ophtalmologistes du Québec pour son soutient financier.

Calendrier des prochaines réunions: cliquez ici.

*** Le visionnement des conférences en différé ne donne pas le droit à des crédits ***

11 mai 2021 Rétine
ROP in low and middle income countries.
Présenté par Professor Clare Gilbert (London School of Hygiene & Tropical Medicine, UK)
Biographies

Professor Clare Gilbert MB ChB., FRCOphth., MD., MSc, trained in surgical retina and worked as a clinical ophthalmologist in the UK for 10 years. She has worked at the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine, UK since 1990. Her main research interest is blindness in children in low and middle income countries, including refractive errors, ROP, cataract and primary eye care. She has undertaken studies in collaboration with colleagues in Latin America, Africa and Asia.

Clare is a technical advisor to several non-government organizations including the Vision Impact Institute, the USAID Child Blindness Program, and until recently, the Queen Elizabeth Diamond Jubilee Trust (the Trust). She has provided technical advice to two large scale programmes in India for ROP and diabetic retinopathy supported by The Trust.

Clare has facilitated over 30 workshops on ROP across Latin America and in Vietnam, Central Europe, Ukraine, Russia, Pakistan and Bangladesh. She was a member of a group who contributed to PAHO’s Guidelines on ROP for South and Central America, and is chairing ICOs working group who will develop global ROP guidelines.

Clare is an author of almost 350 peer reviewed publications (more than 50 on ROP), and has written 26 book chapters. She has received several international awards, including the Jules Francois Golden Award (ICO), and International Prevention of Blindness Award (AAO) and the Barrie Jones Award (Royal College of Ophthalmology).

9 mars 2021 Histopathologie
Présentation des résidents R5 « Corrélations histopathologiques de cas cliniques ».
Présenté par nos résidents de 5e année: Cyril Archambault, Cristina Bostan, Sarah Chorfi, Marie-Pier Matton et Louis Vaillancourt.
9 février 2021 Uvéite
Infectious retinitis: not everything in uveitis is treated with steroids.
Présenté par Dre Debra A. Goldstein (Northwestern University Feinberg School of Medicine, Chicago)
Biographies

Debra Anne Goldstein, MD, FRCSC
Magerstadt Professor of Ophthalmology
Director, Uveitis Service
Director, Uveitis Fellowship
Department of Ophthalmology
Northwestern University Feinberg School of MedicineDr. Debra Anne Goldstein received her medical degree from McGill University in Montreal, Canada, where she subsequently completed an ophthalmology residency. She then pursued a fellowship in uveitis and ocular immunology at McGill followed by a second fellowship in uveitis at the University of Illinois at Chicago. Dr. Goldstein has published over 250 peer-reviewed papers and book chapters and has lectured widely all over the world. She has conducted extensive investigator initiated and multicenter research projects. She has been the recipient of numerous awards and honors including the Senior Achievement Award from the American Academy of Ophthalmology, the Life Achievement Honor award from the American Academy of Ophthalmology, the AAO Secretariat Award for special contributions to the Academy, Unsung Hero recognition from the AAO, as well as an AOA clinical teaching award. She was twice awarded the Golden Apple Award for Best Teacher in Ophthalmology when she was a professor at the University of Illinois at Chicago. In April of 2017 she was awarded the prestigious Magerstadt Professorship in Ophthalmology. In 2021 she became an ARVO Silver Fellow. Dr. Goldstein is currently the Magerstadt Professor of Ophthalmology as well as the Director of the Uveitis Service in the Department of Ophthalmology at Northwestern University’s Feinberg School of Medicine.

12 janvier 2021 Uvéite
Update on masquerade syndrome and vitreoretinal lymphoma.
Présenté par Dre Elisabetta Miserocchi (San Raffaele Scientific Institute, Milan, Italy)
Biographies

Elisabetta MiserocchiSan Raffaele Scientific Institute, Milan, ItalyProfessor Elisabetta Miserocchi is a Consultant Ophthalmologist of the Ocular Immunology and Uveitis Service, based at University Hospital San Raffaele Milan, Italy in the department of Professor Francesco Bandello. After graduating with a medical degree from the University of Milan in 1996, Professor Miserocchi completed a four-year residency in the Department of Ophthalmology at the San Raffaele Scientific Institute, including a 2 two year research fellowship at the Massachusetts Eye and Ear Infirmary, part of Harvard Medical School, Massachusetts, USA with Dr. Stephen Foster.Her main areas of interest and activity are diagnosis and treatment of uveitis, pediatric uveitis associated with rheumatic diseases, ocular cicatricial pemphigoid, herpetic ocular disease. And intraocular lymphoma. Professor Miserocchi is also currently participating to many international multicentre clinical trials on systemic immunosuppressive agents for non infectious uveitis. Professor Miserocchi is a member of the International Uveitis Study Group and the American Uveitis Society. Professor Miserocchi is widely published in peer-reviewed journals and has presented her work at a number of national and international congresses; she was awarded the SOI-SOE Lecture at the Società Oftalmologica Italiana 2012 annual meeting in Rome for new treatments in non-infectious uveitis, and she received the American Academy of Ophthalmology Award in 2015. Dr Miserocchi has conducted research and applied new therapies to further the diagnosis and treatment of non-infectious uveitis.

2 décembre 2020 Rétine
Thérapie génique de la mutation héréditaire du gène RPE65 : Une première au Canada!
Présenté par Dre Cynthia Qian et Dr Flavio Rezende (UMontréal)
Biographies

Dre Cynthia Qian, MD, FRCSCEmail: cynthia.xin-ya.qian@umontreal.ca
Publications: PubMed
Clinical Interests: Surgical retina, Adult and pediatric retinal diseases; Inherited retinal diseasesCynthia X. Qian est professeure adjointe au département d’ophtalmologie et chef du laboratoire d’électrophysiologie et de la section rétine pédiatrique de l’Université de Montréal. Dr. Qian a terminé ses études en médecine à l’Université McGill. Elle a ensuite poursuivi sa résidence à l’Université de Montréal où elle a été élue résidente en chef. Elle a gradué en tant que valédictorienne sur la liste de la Doyenne. Elle est doublement formée en fellowship de rétine chirurgicale au Massachusetts Eye and Ear Infirmary du Harvard Medical School et en maladies héréditaires de la rétine au Kellogg Eye Center de l’Universitee de Michigan.
Elle est actuellement vice-présidente de la Société Canadienne de la rétine et la représentante provinciale pour le Québec en ophtalmologie sur le comité de surspécialité du Collège royal des médecins et chirurgiens du Canada.Ses principaux intérêts de recherche portent sur les essais cliniques sur de nouvelles thérapies dans les maladies héréditaires de la rétine. Elle est experte sur les pathologies de la rétine pédiatrique et les dystrophies rétiniennes, en particulier sur l’implantation chirurgicale des prothèses rétiniennes et l’administration sous-rétinienne de thérapie génique.
Dr. Qian est reconnue pour son travail novateur en tant qu’étoile montante en ophtalmologie clinique, chirurgicale, et en recherche. Elle a été élue « Jeune professionnelle de l’année » par la Jeune Chambre de commerce de Montréal en 2018 et comme lauréate du Top 40 under 40 au Canada en 2019.

Dr Flavio Rezende, MD, PhD

Dr Flavio Rezende, Md. PhD est professeur agrégé de clinique au Département d’ophtalmologie de l’Université de Montréal, et Ophtalmologiste chirurgien vitreo-retinien au Centre universitaire d’ophtalmologie de l’Hôpital Maisonneuve-Rosemont
En tant que professeur agrégé du Département d’ophtalmologie de l’Université de Montréal (UdeM), je dirige le volet clinique / chirurgical de notre équipe de recherche translationnelle au Centre Universitaire d’Ophtalmologie, Hôpital Maisonneuve-Rosemont (CUO-HMR), Montréal, Québec , Canada. Mon objectif principal est la prise en charge chirurgicale des maladies vitréo-rétiniennes compliquées, l’enseignement universitaire et la recherche translationnelle chirurgicale.
En tant que chirurgien vitréo-rétinien, j’ai développé et amélioré des techniques chirurgicales complexes pour gérer les maladies vitréo-rétiniennes. J’ai également développé des techniques chirurgicales pour obtenir des biopsies vitreuses en milieu ambulatoire, fournissant du matériel instrumental pour notre unité de recherche en biologie neuro-vasculaire. Nous construisons actuellement une bio-banque d’échantillons d’humeur vitreuse et aqueuse.
En tant que chercheur translationnel en chirurgie, depuis 5 ans, je suis impliqué dans l’implant Retinal Chip, développant une technique chirurgicale innovante pour une puce rétinienne de nouvelle génération.
Sur le plan académique, j’ai été chargé du programme de bourses vitréo-rétiniennes du Service de la rétine, Département d’ophtalmologie, UdeM pendant 5 ans (2013-2018).
Et au cours de la dernière année, j’ai occupé le poste de directeur clinique au CUO-HMR et, à ce titre, je me suis engagé à apporter davantage d’innovation au profit de nos patients. Des projets en cours feront de notre centre universitaire d’ophtalmologie, l’un des premiers centres au Canada de thérapie génique pour des affections rétiniennes auparavant incurables.

10 novembre 2020 Glaucome
MIGS: L’embarras du choix!
Présenté par Dre Susan Wakil, Dre Qianqian Wang et Dr Georges Durr (Université de Montréal)
Biographies

Dre Susan Wakil, MD, FRCSC

Dr Wakil a complété ses études médicales et sa résidence en ophtalmologie à l’Université de McGill sur la liste d’honneur du Doyen. Elle a par la suite complété sa formation de surspécialité en glaucome chirurgical au centre renommé de l’Université Duke en Caroline du Nord, E-U, ou elle a obtenu le prix « Hornaday Fellow of the Year Award ». Lors de sa deuxième année à l’Université Duke elle a travaillé en tant que clinicienne associée et a entamé un fellowship de recherche portant sur plusieurs sujets tels l’intelligence artificielle, les chirurgies du glaucome et la génétique du glaucome en Afrique. Elle complète actuellement une maîtrise en Santé Publique avec l’Université de Hopkins, E-U. Elle est professeur adjoint de clinique à l’Université de Montréal et pratique principalement à l’Hôpital Sacré-Cœur de Montréal ainsi que dans d’autres centres hospitaliers.

Dre Qianqian Wang, MD, FRCSC

Après avoir obtenu son doctorat en médecine à l’Université McGill, Dre Qianqian Wang a poursuivi sa formation en ophtalmologie à l’Université de Montréal. Elle a ensuite complété sa formation de surspécialité en glaucome chirurgical au renommé Hôpital Wills Eye à Philadelphie, É.-U. À son retour à Montréal, elle a également complété un fellowship en recherche sur la neurorégénération au laboratoire de la Dre Adriana Di Polo au Centre de Recherche de CHUM. Dre Wang est l’auteure de nombreux articles scientifiques et présente régulièrement aux congrès nationaux et internationaux. Elle est professeur adjoint de clinique à l’Université de Montréal et pratique au CHUM, Clinique Ophtalmologique Berri et Hôpital Lachine. Son champ d’intérêt inclut les traitements médicaux et chirurgicaux traditionnels et innovants en glaucome ainsi que la recherche clinique en glaucome.

Dr Georges Durr, MD, FRCSC

Dr Durr a complété son baccalauréat, sa médecine et sa résidence en ophtalmologie à l’Université de Montréal. Il a obtenu son bac en sciences biomédicales sur la liste d’honneur du Doyen. Par la suite, il a poursuivi sa formation avec un fellowship de 2 ans en Glaucome et Chirurgie Complexe du Segment Antérieur à l’Université de Toronto en autre sous la tutelle du Dr Ike Ahmed. Ses activités de recherche touche surtout les nouvelles innovations en glaucome, cataracte et la reconstruction du segment antérieur. Présentement, il pratique à l’Université de Montréal au CHUM (Centre Hospitalier Universitaire de Montreal). Il est professeur adjoint de clinique et directeur du fellowship en glaucome à l’Université de Montréal.

20 octobre 2020 Oculoplastie
Bench to Bedside: Evolution of Therapy for Thyroid Associated Ophthalmopathy
Présenté par Dr Terry Smith (Kellogg Eye Center)
Biographie

Terry J. Smith, M.D.
Frederick G.L. Huetwell Professor of Ophthalmology and Visual Sciences
Professor, Department of Internal Medicine
Kellog Eye Center
University of Michigan

Biography
Dr. Terry J. Smith, the Frederick G.L. Huetwell Professor in Ophthalmology and Visual Sciences at the University of Michigan, is an internationally-known endocrinologist who has studied Graves’ disease, its eye manifestations, and related autoimmune disease for over 20 years. Dr. Smith’s laboratory was first to describe the unique molecular attributes of tissue surrounding the eye that make it susceptible to inflammation in Graves’ disease. He has identified a novel autoantibody that binds to and activates a specific receptor, resulting in an exaggerated autoimmune response. His investigation of these mechanisms has yielded several potential therapeutic targets that may interrupt the disease process. These will provide the focus for future clinical trials.

Dr. Smith received his medical degree from the University of Missouri School of Medicine and completed his residency at the University of Illinois in Chicago and Sinai Hospital in Baltimore. He has completed fellowships in biophysics at the University of California School of Medicine, San Francisco, in molecular biochemistry at Columbia University in New York, and clinical endocrinology at the Pritzker School of Medicine, University of Chicago.

Dr. Smith is the author of over 150 articles and book chapters, and has been awarded five patents for his research discoveries. He has been elected to the Orbit Society, is chief scientific officer for the National Graves’ Foundation, and serves as reviewer for numerous scientific journals. Dr. Smith has been funded continuously by the National Institutes of Health and the Veterans Administration since 1983.

Areas of Interest

Research Areas
Clinical Trials – Eye Plastics

Research Summary
Autoimmune thyroid disease, extracellular matrix, cell signaling, gene expression, ecosanoids, inflammation and cytokine action

Dr. Smith’s laboratory group is interested in understanding and developing new treatments for Graves’ Disease (GD) or thyroid-associated ophthalmopathy (TAO).

Graves’ Disease is an autoimmune process directed primarily at the thyroid. Many of the patients with GD also exhibit inflammation of the tissues around the eye. Orbital manifestations of GD known as TAO, involve the dramatic remodeling of connective tissues surrounding the eye. Alterations in orbital tissue architecture can adversely affect the function and health of the eye in several ways.

  • They can deprive the globe of normal irrigation and eyelid coverage, leading to chronic irritation and infection.
  • They can compromise the ability of the eyes to move in a coordinated fashion, restricting motility, and resulting in disconjugate gaze and diplopia.
  • They can cause cosmetic changes that sometimes exert a profoundly deleterious impact on the psychological health of afflicted patients.
  • They can threaten eye sight by compressing the neuro-vascular supply to the eye.

There are no specific safe and effective therapies for TAO. Our overall goal is to identify the molecular and cellular mechanisms responsible for the pathogenesis of orbital involvement in TAO. We have found that patients with TAO have dramatically increased numbers of circulating fibrocytes. These fibrocytes derive from stem cells originating in the bone marrow. They infiltrate the connective tissues of the orbit. We believe that the phenotypic attributes of orbital fibroblasts underlie the propensity of the tissues surrounding the eye to become involved in GD. As a direct consequence of identifying the peculiarities exhibited by these cells, we are now in a strong position to create strategies for interrupting the disease process at a very early stage.

Their work is focused on defining the molecular targets that will lead to effective and specific therapy design.

Clinical Interests

Graves’ disease, thyroid-associated ophthalmopathy, metabolic diseases

Specialties: Endocrinology, Internal Medicine

Honors & Awards

2018

  • Merit Award, University of Missouri School of Medicine
  • Clinical Trial, A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating Teprotumumab (HZN-001) Treatment in Subjects with Active Thyroid Eye Disease (OPTIC) – INC Research/Horizon Pharma USA, Inc.

2017

  • River Vision Pilot Study; River Vision

Credentials

  • Medical School – University of Missouri School of Medicine, 1975
  • Residencies
    • Department of Medicine, University of Illinois, Chicago, IL, 1976
    • Department of Medicine, Sinai Hospital, Baltimore, MD, 1977
  • Fellowships
    • Biophysics, Cardiovascular Research Institute, University of California School of Medicine, San Francisco, CA, 1978
    • Biochemistry, Columbia University, New York, NY, 1979
    • Endocrinology, Pritzker School of Medicine, University of Chicago, Chicago, IL, 1981

Published Articles or Reviews
View a list of publications on Michigan Experts

Source = https://medicine.umich.edu/dept/ophthalmology/terry-j-smith-md

15 septembre 2020 Cornée et segment antérieur
Cataract Surgery in Patients with Corneal Disease: Pearls and Pitfalls.

Présenté par Dr Anthony J. Aldave (UCLA)

Biographie

Anthony J. Aldave, M.D.
Professor of Ophthalmology
Walton Li Chair in Cornea and Uveitis
Chief, Cornea and Uveitis Division
Director, Cornea and Refractive Surgery Fellowship
The Stein Eye Institute

Anthony J. Aldave, MD, received his medical degree from the University of Texas Medical Branch in Galveston. He performed his residency training in ophthalmology at the Wills Eye Hospital, Thomas Jefferson University, in Philadelphia, Pennsylvania.  Dr. Aldave then completed a two-year Cornea, Uveitis and Refractive Surgery Fellowship at The University of California, San Francisco/ Francis I. Proctor Foundation.  He joined the Stein Eye Institute in July 2002 as a full-time member of the Cornea and Refractive Surgery Services.  Dr. Aldave is currently a Professor of Ophthalmology, holds the Walton Li Chair in Cornea and Uveitis, is Chief of the Cornea and Uveitis Division and Director of the Cornea and Refractive Surgery Fellowship Program.

Dr. Aldave has received numerous honors during his career, including the Alpha Omega Alpha Scholarship Award for graduating first in his medical school class, the Heed Ophthalmic Foundation Fellowship, the American Ophthalmological Society-Knapp Testimonial Fund Fellowship, the first Claes Dohlman Society Award, and the Achievement, Secretariat and Senior Achievement Awards from the American Academy of Ophthalmology.

In addition to his busy clinical practice, Dr. Aldave directs the Corneal Genetics Laboratory at the Stein Eye Institute.  Dr. Aldave’s laboratory research focuses on the molecular genetics of the corneal dystrophies, a group of inherited disorders that affect corneal clarity and constitute one of the primary indications for corneal transplantation.  Recognized as a leader in his chosen field of scientific investigation, Dr. Aldave has authored over 150 peer-reviewed scientific publications, has been invited to give almost 450 scientific presentations at local, national and international meetings and serves as a scientific reviewer for 19 ophthalmology and genetics journals.

9 juin 2020 Cornée et segment antérieur
La chirurgie de la cataracte bilatérale simultanée.
Présenté par Dre Marie-Ève Légaré (Université Laval)
Biographie